Smart Factory: Digitalizing production facilities Smart Factory: Digitalizing production facilities How our digitalized production facilities help our colleagues and patients
Veterinarians: caught between excellence and exhaustion Veterinarians: caught between excellence and exhaustion Many children dream of becoming a veterinarian. What happens when that dream comes true?
FDA- HFpEF-breakthrough-designation-EMPEROR-preserved FDA- HFpEF-breakthrough-designation-EMPEROR-preserved U.S. FDA issues Breakthrough Therapy Designation for the treatment of adults with heart failure with preserved ejection fraction
Netherton syndrome (NS) Netherton syndrome (NS) Information on Netherton syndrome (NS), a severe, ultra-rare multisystem disorder which has a life-altering impact across a person’s life.
Life forward - Boehringer Ingelheim company brand Life forward - Boehringer Ingelheim company brand Life forward - Boehringer Ingelheim unveils its evolved company brand
The Unwearable Collection™ Evolution The Unwearable Collection™ Evolution Get ready for the next stage of The Unwearable Collection™
Odile Bain Memorial Prize 2021 Odile Bain Memorial Prize 2021 Brilliant early-career scientists in parasitology recognized
discontinuation-bi-1467335-diabetic-retinopathy discontinuation-bi-1467335-diabetic-retinopathy The discontinuation of the development of BI 1467335 in diabetic retinopathy has been announced
Research Beyond Borders Partnering Research Beyond Borders Partnering Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.
Reduction of Salmonella in swine after vaccination Reduction of Salmonella in swine after vaccination Authorities acknowledge reduction of Salmonella after vaccination with Enterisol® Ileitis
Making a difference with data science Making a difference with data science Our Head of Central Data Science, Brigitte Fuhr joined the team to make a difference to patients’ lives.
preserved-heart-failure-treatment-FDA-US-approval preserved-heart-failure-treatment-FDA-US-approval US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction
preserved-heart-failure-treatment-approval-europe preserved-heart-failure-treatment-approval-europe preserved-heart-failure-treatment-approval-europe
2019 performance 2019 performance Global Support Program addresses COVID-19 crisis with relief fund initiatives and volunteering support, donations, and concrete research activities.
Advance study vaccinating increased milk production Advance study vaccinating increased milk production [New ADVANCE study shows vaccinating with Bovela® results in increased milk production
Big molecules - Huge potential | Bioxcellence | Boehringer Ingelheim Big molecules - Huge potential | Bioxcellence | Boehringer Ingelheim Explore the potential of big molecules with BioXcellence, offering advanced biopharmaceutical production services to unlock new possibilities in healthcare.
3 tips for anyone interested in a STEM career 3 tips for anyone interested in a STEM career What does it take to pursue a career in science? We asked Dr. Joanne Maki, a Boehringer Ingelheim veterinarian and scientist based in Athens, Ga.
emperor-preserved-heart-failure-full-data emperor-preserved-heart-failure-full-data Full results from EMPEROR-Preserved trial demonstrate significant improvement in heart failure outcomes in adults with preserved ejection fraction
Phase II clinical trial weight loss results Phase II clinical trial weight loss results Data shows nearly 19% weight loss in people with overweight or obesity in Phase II trial with survodutide (BI 456906)
Are combination therapies the answer to battling KRAS cancers? Are combination therapies the answer to battling KRAS cancers? Dr Ulrich Dünzinger and Kristie Fernamberg talk about their work with the SOS1 KRAS inhibitor to block tumour-triggering signal
Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products
Building Successful Partnerships in Animal Health Building Successful Partnerships in Animal Health Christoph Vetten, Head of Transactions Animal Health, shares his perspectives on how building successful collaborations can drive innovation.
emperor-reduced-chmp-positive-opinion emperor-reduced-chmp-positive-opinion CHMP issues positive opinion for the treatment of adults with heart failure with reduced ejection fraction
Boehringer Ingelheim reaches more patients than ever, innovation drives growth Boehringer Ingelheim reaches more patients than ever, innovation drives growth Boehringer Ingelheim reports a strong performance in 2022.
Partnering-with-google-in-quantum-computing Partnering-with-google-in-quantum-computing New cooperation with Google explores the potentials of quantum computing for pharma R&D.